Global Hemostatic Agents Market Insights and Forecast to 2028

Report ID: 1201155 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Hemostatic Agents Product Introduction
    1.2 Market by Type
        1.2.1 Global Hemostatic Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Gelation Sponge
        1.2.3 Oxidized Regenerated Cellulose Based Hemostats
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Hemostatic Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Surgical Centers
        1.3.4 Nursing Homes
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Hemostatic Agents Sales Estimates and Forecasts 2017-2028
    2.2 Global Hemostatic Agents Revenue Estimates and Forecasts 2017-2028
    2.3 Global Hemostatic Agents Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Hemostatic Agents Sales by Region
        2.4.1 Global Hemostatic Agents Sales by Region (2017-2022)
        2.4.2 Global Sales Hemostatic Agents by Region (2023-2028)
    2.5 Global Hemostatic Agents Revenue by Region
        2.5.1 Global Hemostatic Agents Revenue by Region (2017-2022)
        2.5.2 Global Hemostatic Agents Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Hemostatic Agents Sales by Manufacturers
        3.1.1 Global Top Hemostatic Agents Manufacturers by Sales (2017-2022)
        3.1.2 Global Hemostatic Agents Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hemostatic Agents in 2021
    3.2 Global Hemostatic Agents Revenue by Manufacturers
        3.2.1 Global Hemostatic Agents Revenue by Manufacturers (2017-2022)
        3.2.2 Global Hemostatic Agents Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Hemostatic Agents Revenue in 2021
    3.3 Global Hemostatic Agents Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Hemostatic Agents Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Hemostatic Agents Sales by Type
        4.1.1 Global Hemostatic Agents Historical Sales by Type (2017-2022)
        4.1.2 Global Hemostatic Agents Forecasted Sales by Type (2023-2028)
        4.1.3 Global Hemostatic Agents Sales Market Share by Type (2017-2028)
    4.2 Global Hemostatic Agents Revenue by Type
        4.2.1 Global Hemostatic Agents Historical Revenue by Type (2017-2022)
        4.2.2 Global Hemostatic Agents Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Hemostatic Agents Revenue Market Share by Type (2017-2028)
    4.3 Global Hemostatic Agents Price by Type
        4.3.1 Global Hemostatic Agents Price by Type (2017-2022)
        4.3.2 Global Hemostatic Agents Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Hemostatic Agents Sales by Application
        5.1.1 Global Hemostatic Agents Historical Sales by Application (2017-2022)
        5.1.2 Global Hemostatic Agents Forecasted Sales by Application (2023-2028)
        5.1.3 Global Hemostatic Agents Sales Market Share by Application (2017-2028)
    5.2 Global Hemostatic Agents Revenue by Application
        5.2.1 Global Hemostatic Agents Historical Revenue by Application (2017-2022)
        5.2.2 Global Hemostatic Agents Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Hemostatic Agents Revenue Market Share by Application (2017-2028)
    5.3 Global Hemostatic Agents Price by Application
        5.3.1 Global Hemostatic Agents Price by Application (2017-2022)
        5.3.2 Global Hemostatic Agents Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Hemostatic Agents Market Size by Type
        6.1.1 North America Hemostatic Agents Sales by Type (2017-2028)
        6.1.2 North America Hemostatic Agents Revenue by Type (2017-2028)
    6.2 North America Hemostatic Agents Market Size by Application
        6.2.1 North America Hemostatic Agents Sales by Application (2017-2028)
        6.2.2 North America Hemostatic Agents Revenue by Application (2017-2028)
    6.3 North America Hemostatic Agents Market Size by Country
        6.3.1 North America Hemostatic Agents Sales by Country (2017-2028)
        6.3.2 North America Hemostatic Agents Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Hemostatic Agents Market Size by Type
        7.1.1 Europe Hemostatic Agents Sales by Type (2017-2028)
        7.1.2 Europe Hemostatic Agents Revenue by Type (2017-2028)
    7.2 Europe Hemostatic Agents Market Size by Application
        7.2.1 Europe Hemostatic Agents Sales by Application (2017-2028)
        7.2.2 Europe Hemostatic Agents Revenue by Application (2017-2028)
    7.3 Europe Hemostatic Agents Market Size by Country
        7.3.1 Europe Hemostatic Agents Sales by Country (2017-2028)
        7.3.2 Europe Hemostatic Agents Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Hemostatic Agents Market Size by Type
        8.1.1 Asia Pacific Hemostatic Agents Sales by Type (2017-2028)
        8.1.2 Asia Pacific Hemostatic Agents Revenue by Type (2017-2028)
    8.2 Asia Pacific Hemostatic Agents Market Size by Application
        8.2.1 Asia Pacific Hemostatic Agents Sales by Application (2017-2028)
        8.2.2 Asia Pacific Hemostatic Agents Revenue by Application (2017-2028)
    8.3 Asia Pacific Hemostatic Agents Market Size by Region
        8.3.1 Asia Pacific Hemostatic Agents Sales by Region (2017-2028)
        8.3.2 Asia Pacific Hemostatic Agents Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Hemostatic Agents Market Size by Type
        9.1.1 Latin America Hemostatic Agents Sales by Type (2017-2028)
        9.1.2 Latin America Hemostatic Agents Revenue by Type (2017-2028)
    9.2 Latin America Hemostatic Agents Market Size by Application
        9.2.1 Latin America Hemostatic Agents Sales by Application (2017-2028)
        9.2.2 Latin America Hemostatic Agents Revenue by Application (2017-2028)
    9.3 Latin America Hemostatic Agents Market Size by Country
        9.3.1 Latin America Hemostatic Agents Sales by Country (2017-2028)
        9.3.2 Latin America Hemostatic Agents Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Hemostatic Agents Market Size by Type
        10.1.1 Middle East and Africa Hemostatic Agents Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Hemostatic Agents Revenue by Type (2017-2028)
    10.2 Middle East and Africa Hemostatic Agents Market Size by Application
        10.2.1 Middle East and Africa Hemostatic Agents Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Hemostatic Agents Revenue by Application (2017-2028)
    10.3 Middle East and Africa Hemostatic Agents Market Size by Country
        10.3.1 Middle East and Africa Hemostatic Agents Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Hemostatic Agents Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Ethicon
        11.1.1 Ethicon Corporation Information
        11.1.2 Ethicon Overview
        11.1.3 Ethicon Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Ethicon Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Ethicon Recent Developments
    11.2 Pfizer
        11.2.1 Pfizer Corporation Information
        11.2.2 Pfizer Overview
        11.2.3 Pfizer Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Pfizer Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Pfizer Recent Developments
    11.3 Baxter International
        11.3.1 Baxter International Corporation Information
        11.3.2 Baxter International Overview
        11.3.3 Baxter International Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Baxter International Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Baxter International Recent Developments
    11.4 C. R. Bard
        11.4.1 C. R. Bard Corporation Information
        11.4.2 C. R. Bard Overview
        11.4.3 C. R. Bard Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 C. R. Bard Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 C. R. Bard Recent Developments
    11.5 The Medicines Company
        11.5.1 The Medicines Company Corporation Information
        11.5.2 The Medicines Company Overview
        11.5.3 The Medicines Company Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 The Medicines Company Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 The Medicines Company Recent Developments
    11.6 Anika Therapeutics
        11.6.1 Anika Therapeutics Corporation Information
        11.6.2 Anika Therapeutics Overview
        11.6.3 Anika Therapeutics Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Anika Therapeutics Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Anika Therapeutics Recent Developments
    11.7 Advanced Medical Solutions
        11.7.1 Advanced Medical Solutions Corporation Information
        11.7.2 Advanced Medical Solutions Overview
        11.7.3 Advanced Medical Solutions Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Advanced Medical Solutions Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Advanced Medical Solutions Recent Developments
    11.8 Integra LifeSciences
        11.8.1 Integra LifeSciences Corporation Information
        11.8.2 Integra LifeSciences Overview
        11.8.3 Integra LifeSciences Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Integra LifeSciences Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Integra LifeSciences Recent Developments
    11.9 B Braun Melsungen
        11.9.1 B Braun Melsungen Corporation Information
        11.9.2 B Braun Melsungen Overview
        11.9.3 B Braun Melsungen Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 B Braun Melsungen Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 B Braun Melsungen Recent Developments
    11.10 Gelita Medical
        11.10.1 Gelita Medical Corporation Information
        11.10.2 Gelita Medical Overview
        11.10.3 Gelita Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Gelita Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Gelita Medical Recent Developments
    11.11 Equimedical
        11.11.1 Equimedical Corporation Information
        11.11.2 Equimedical Overview
        11.11.3 Equimedical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Equimedical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Equimedical Recent Developments
    11.12 Vascular Solutions
        11.12.1 Vascular Solutions Corporation Information
        11.12.2 Vascular Solutions Overview
        11.12.3 Vascular Solutions Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Vascular Solutions Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Vascular Solutions Recent Developments
    11.13 Marine Polymer Technologies
        11.13.1 Marine Polymer Technologies Corporation Information
        11.13.2 Marine Polymer Technologies Overview
        11.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Marine Polymer Technologies Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Marine Polymer Technologies Recent Developments
    11.14 Z-Medica
        11.14.1 Z-Medica Corporation Information
        11.14.2 Z-Medica Overview
        11.14.3 Z-Medica Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Z-Medica Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Z-Medica Recent Developments
    11.15 CryoLife
        11.15.1 CryoLife Corporation Information
        11.15.2 CryoLife Overview
        11.15.3 CryoLife Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 CryoLife Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 CryoLife Recent Developments
    11.16 BioCer Entwicklungs
        11.16.1 BioCer Entwicklungs Corporation Information
        11.16.2 BioCer Entwicklungs Overview
        11.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 BioCer Entwicklungs Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 BioCer Entwicklungs Recent Developments
    11.17 Biom’Up SAS
        11.17.1 Biom’Up SAS Corporation Information
        11.17.2 Biom’Up SAS Overview
        11.17.3 Biom’Up SAS Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Biom’Up SAS Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Biom’Up SAS Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Hemostatic Agents Industry Chain Analysis
    12.2 Hemostatic Agents Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Hemostatic Agents Production Mode & Process
    12.4 Hemostatic Agents Sales and Marketing
        12.4.1 Hemostatic Agents Sales Channels
        12.4.2 Hemostatic Agents Distributors
    12.5 Hemostatic Agents Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Hemostatic Agents Industry Trends
    13.2 Hemostatic Agents Market Drivers
    13.3 Hemostatic Agents Market Challenges
    13.4 Hemostatic Agents Market Restraints
14 Key Findings in The Global Hemostatic Agents Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Hemostatic Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Gelation Sponge
    Table 3. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats
    Table 4. Major Manufacturers of Others
    Table 5. Global Hemostatic Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Hemostatic Agents Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Hemostatic Agents Sales by Region (2017-2022) & (K Units)
    Table 8. Global Hemostatic Agents Sales Market Share by Region (2017-2022)
    Table 9. Global Hemostatic Agents Sales by Region (2023-2028) & (K Units)
    Table 10. Global Hemostatic Agents Sales Market Share by Region (2023-2028)
    Table 11. Global Hemostatic Agents Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Hemostatic Agents Revenue Market Share by Region (2017-2022)
    Table 13. Global Hemostatic Agents Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Hemostatic Agents Revenue Market Share by Region (2023-2028)
    Table 15. Global Hemostatic Agents Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Hemostatic Agents Sales Share by Manufacturers (2017-2022)
    Table 17. Global Hemostatic Agents Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Hemostatic Agents Revenue Share by Manufacturers (2017-2022)
    Table 19. Hemostatic Agents Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Hemostatic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Agents as of 2021)
    Table 22. Hemostatic Agents Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Hemostatic Agents Product Offered
    Table 24. Date of Manufacturers Enter into Hemostatic Agents Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Hemostatic Agents Sales by Type (2017-2022) & (K Units)
    Table 27. Global Hemostatic Agents Sales by Type (2023-2028) & (K Units)
    Table 28. Global Hemostatic Agents Sales Share by Type (2017-2022)
    Table 29. Global Hemostatic Agents Sales Share by Type (2023-2028)
    Table 30. Global Hemostatic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Hemostatic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Hemostatic Agents Revenue Share by Type (2017-2022)
    Table 33. Global Hemostatic Agents Revenue Share by Type (2023-2028)
    Table 34. Hemostatic Agents Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Hemostatic Agents Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Hemostatic Agents Sales by Application (2017-2022) & (K Units)
    Table 37. Global Hemostatic Agents Sales by Application (2023-2028) & (K Units)
    Table 38. Global Hemostatic Agents Sales Share by Application (2017-2022)
    Table 39. Global Hemostatic Agents Sales Share by Application (2023-2028)
    Table 40. Global Hemostatic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Hemostatic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Hemostatic Agents Revenue Share by Application (2017-2022)
    Table 43. Global Hemostatic Agents Revenue Share by Application (2023-2028)
    Table 44. Hemostatic Agents Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Hemostatic Agents Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Hemostatic Agents Sales by Type (2017-2022) & (K Units)
    Table 47. North America Hemostatic Agents Sales by Type (2023-2028) & (K Units)
    Table 48. North America Hemostatic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Hemostatic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Hemostatic Agents Sales by Application (2017-2022) & (K Units)
    Table 51. North America Hemostatic Agents Sales by Application (2023-2028) & (K Units)
    Table 52. North America Hemostatic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Hemostatic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Hemostatic Agents Sales by Country (2017-2022) & (K Units)
    Table 55. North America Hemostatic Agents Sales by Country (2023-2028) & (K Units)
    Table 56. North America Hemostatic Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Hemostatic Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Hemostatic Agents Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Hemostatic Agents Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Hemostatic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Hemostatic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Hemostatic Agents Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Hemostatic Agents Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Hemostatic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Hemostatic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Hemostatic Agents Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Hemostatic Agents Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Hemostatic Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Hemostatic Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Hemostatic Agents Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Hemostatic Agents Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Hemostatic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Hemostatic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Hemostatic Agents Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Hemostatic Agents Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Hemostatic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Hemostatic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Hemostatic Agents Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Hemostatic Agents Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Hemostatic Agents Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Hemostatic Agents Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Hemostatic Agents Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Hemostatic Agents Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Hemostatic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Hemostatic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Hemostatic Agents Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Hemostatic Agents Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Hemostatic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Hemostatic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Hemostatic Agents Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Hemostatic Agents Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Hemostatic Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Hemostatic Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Hemostatic Agents Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Hemostatic Agents Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Hemostatic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Hemostatic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Hemostatic Agents Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Hemostatic Agents Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Hemostatic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Hemostatic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Hemostatic Agents Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Hemostatic Agents Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Hemostatic Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Hemostatic Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Ethicon Corporation Information
    Table 107. Ethicon Description and Major Businesses
    Table 108. Ethicon Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Ethicon Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Ethicon Recent Developments
    Table 111. Pfizer Corporation Information
    Table 112. Pfizer Description and Major Businesses
    Table 113. Pfizer Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Pfizer Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Pfizer Recent Developments
    Table 116. Baxter International Corporation Information
    Table 117. Baxter International Description and Major Businesses
    Table 118. Baxter International Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Baxter International Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Baxter International Recent Developments
    Table 121. C. R. Bard Corporation Information
    Table 122. C. R. Bard Description and Major Businesses
    Table 123. C. R. Bard Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. C. R. Bard Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. C. R. Bard Recent Developments
    Table 126. The Medicines Company Corporation Information
    Table 127. The Medicines Company Description and Major Businesses
    Table 128. The Medicines Company Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. The Medicines Company Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. The Medicines Company Recent Developments
    Table 131. Anika Therapeutics Corporation Information
    Table 132. Anika Therapeutics Description and Major Businesses
    Table 133. Anika Therapeutics Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Anika Therapeutics Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Anika Therapeutics Recent Developments
    Table 136. Advanced Medical Solutions Corporation Information
    Table 137. Advanced Medical Solutions Description and Major Businesses
    Table 138. Advanced Medical Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Advanced Medical Solutions Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Advanced Medical Solutions Recent Developments
    Table 141. Integra LifeSciences Corporation Information
    Table 142. Integra LifeSciences Description and Major Businesses
    Table 143. Integra LifeSciences Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Integra LifeSciences Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Integra LifeSciences Recent Developments
    Table 146. B Braun Melsungen Corporation Information
    Table 147. B Braun Melsungen Description and Major Businesses
    Table 148. B Braun Melsungen Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. B Braun Melsungen Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. B Braun Melsungen Recent Developments
    Table 151. Gelita Medical Corporation Information
    Table 152. Gelita Medical Description and Major Businesses
    Table 153. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Gelita Medical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Gelita Medical Recent Developments
    Table 156. Equimedical Corporation Information
    Table 157. Equimedical Description and Major Businesses
    Table 158. Equimedical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 159. Equimedical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Equimedical Recent Developments
    Table 161. Vascular Solutions Corporation Information
    Table 162. Vascular Solutions Description and Major Businesses
    Table 163. Vascular Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 164. Vascular Solutions Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Vascular Solutions Recent Developments
    Table 166. Marine Polymer Technologies Corporation Information
    Table 167. Marine Polymer Technologies Description and Major Businesses
    Table 168. Marine Polymer Technologies Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 169. Marine Polymer Technologies Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Marine Polymer Technologies Recent Developments
    Table 171. Z-Medica Corporation Information
    Table 172. Z-Medica Description and Major Businesses
    Table 173. Z-Medica Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 174. Z-Medica Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 175. Z-Medica Recent Developments
    Table 176. CryoLife Corporation Information
    Table 177. CryoLife Description and Major Businesses
    Table 178. CryoLife Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 179. CryoLife Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 180. CryoLife Recent Developments
    Table 181. BioCer Entwicklungs Corporation Information
    Table 182. BioCer Entwicklungs Description and Major Businesses
    Table 183. BioCer Entwicklungs Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 184. BioCer Entwicklungs Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 185. BioCer Entwicklungs Recent Developments
    Table 186. Biom’Up SAS Corporation Information
    Table 187. Biom’Up SAS Description and Major Businesses
    Table 188. Biom’Up SAS Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 189. Biom’Up SAS Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 190. Biom’Up SAS Recent Developments
    Table 191. Key Raw Materials Lists
    Table 192. Raw Materials Key Suppliers Lists
    Table 193. Hemostatic Agents Distributors List
    Table 194. Hemostatic Agents Customers List
    Table 195. Hemostatic Agents Market Trends
    Table 196. Hemostatic Agents Market Drivers
    Table 197. Hemostatic Agents Market Challenges
    Table 198. Hemostatic Agents Market Restraints
    Table 199. Research Programs/Design for This Report
    Table 200. Key Data Information from Secondary Sources
    Table 201. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hemostatic Agents Product Picture
    Figure 3. Global Hemostatic Agents Market Share by Type in 2021 & 2028
    Figure 3. Gelation Sponge Product Picture
    Figure 4. Oxidized Regenerated Cellulose Based Hemostats Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Hemostatic Agents Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Surgical Centers
    Figure 9. Nursing Homes
    Figure 10. Hemostatic Agents Report Years Considered
    Figure 11. Global Hemostatic Agents Sales 2017-2028 (K Units)
    Figure 12. Global Hemostatic Agents Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Hemostatic Agents Revenue 2017-2028 (US$ Million)
    Figure 14. Global Hemostatic Agents Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Hemostatic Agents Sales Market Share by Region (2017-2022)
    Figure 16. Global Hemostatic Agents Sales Market Share by Region (2023-2028)
    Figure 17. North America Hemostatic Agents Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Hemostatic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Hemostatic Agents Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Hemostatic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Hemostatic Agents Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Hemostatic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Hemostatic Agents Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Hemostatic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Hemostatic Agents Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Hemostatic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Hemostatic Agents Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Hemostatic Agents in the World: Market Share by Hemostatic Agents Revenue in 2021
    Figure 29. Global Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Hemostatic Agents Sales Market Share by Type (2017-2028)
    Figure 31. Global Hemostatic Agents Revenue Market Share by Type (2017-2028)
    Figure 32. Global Hemostatic Agents Sales Market Share by Application (2017-2028)
    Figure 33. Global Hemostatic Agents Revenue Market Share by Application (2017-2028)
    Figure 34. North America Hemostatic Agents Sales Market Share by Type (2017-2028)
    Figure 35. North America Hemostatic Agents Revenue Market Share by Type (2017-2028)
    Figure 36. North America Hemostatic Agents Sales Market Share by Application (2017-2028)
    Figure 37. North America Hemostatic Agents Revenue Market Share by Application (2017-2028)
    Figure 38. North America Hemostatic Agents Sales Share by Country (2017-2028)
    Figure 39. North America Hemostatic Agents Revenue Share by Country (2017-2028)
    Figure 40. U.S. Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Hemostatic Agents Sales Market Share by Type (2017-2028)
    Figure 43. Europe Hemostatic Agents Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Hemostatic Agents Sales Market Share by Application (2017-2028)
    Figure 45. Europe Hemostatic Agents Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Hemostatic Agents Sales Share by Country (2017-2028)
    Figure 47. Europe Hemostatic Agents Revenue Share by Country (2017-2028)
    Figure 48. Germany Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 49. France Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Hemostatic Agents Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Hemostatic Agents Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Hemostatic Agents Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Hemostatic Agents Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Hemostatic Agents Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Hemostatic Agents Revenue Share by Region (2017-2028)
    Figure 59. China Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 62. India Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Hemostatic Agents Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Hemostatic Agents Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Hemostatic Agents Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Hemostatic Agents Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Hemostatic Agents Sales Share by Country (2017-2028)
    Figure 74. Latin America Hemostatic Agents Revenue Share by Country (2017-2028)
    Figure 75. Mexico Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Hemostatic Agents Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Hemostatic Agents Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Hemostatic Agents Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Hemostatic Agents Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Hemostatic Agents Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Hemostatic Agents Revenue Share by Country (2017-2028)
    Figure 84. Turkey Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 87. Hemostatic Agents Value Chain
    Figure 88. Hemostatic Agents Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
Frequently Asked Questions
Hemostatic Agents report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hemostatic Agents report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hemostatic Agents report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Circular Push Pull

Circular Push Pull market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

Lactobionic Acid

Lactobionic Acid market is segmented by Type and by Application. Players, stakeholders, and other ... Read More